Here we present the application of a fully validated molecular docking protocol for the rational selection of the most promising N,N’ -disubstituted sulfamides derivatives to be synthesized as potential new hCAVII inhibitors.
General information
Exposure date:2022
Issue date:2022
Document language:English
Event:8th International Electronic Conference on Medicinal Chemistry (ECMC) (On line, 1-30 November, 2022)
Origin:Laboratorio de Investigación y Desarrollo de Bioactivos
Except where otherwise noted, this item's license is described as Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)